Get started

Buy-signal

$GLBS FALLING WEDGE BULLISH REVERSALGlobus Maritime (UPDATE) Currently $3.07 & Targets $35 - $100 Technical Analysis: Bullish Chart Pattern: Falling Wedge Bullish Reversal RSI: Slowly Going Up & Signal For Trend Reversal Volume: Low & Calm Before Storm Fundamental Analysis: Bullish EPS: Expected Late Sept & Extremely Bullish There is huge upside considering $BDI is at a 11 Year High! Also Globus Maritime Stock is near alltime lows of $2.55 & there’s an incredible opportunity for growth. The dry bulk industry can expect major recovery and profits. Retail Investors Are Expected To Be Massively Rewarded!
NASDAQ:GLBSLong
by WALLSTVIDEOS
3
OEG Orbital Energy increased Institutional Ownership On 7/26/2021 Alliance Global Partners brokerage Lowered the Price Target for OEG from $15.00 to $12.00 It`s interesting to see how this month only the institutions increased their ownership in the company with 22mil. Some of the Companies that reported increased ownership in Orbital Energy this months are: Increased ownership in Millennium Management LLC by +326.9% Morgan Stanley by +134.2% Vanguard Group Inc. by +17.7% Morgan Stanley by +84.4% My first target is the 4.5 resistance from which can skyrocket
OLong
by TopgOptions
1
PIRS Pieris Pharmaceuticals Huge Upside Potential Big pharma working with Pieris Pharmaceuticals, Inc. (PIRS): AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments Genentech member of RHHBY Roche Group 20Mil upfront payment and 1.4Bil potential milestone payments SGEN Seagen 35Mil upfront payment and 1.2Bil potential milestone payments Servier 40Mil upfront payment and 447Mil potential milestone payments inhaled program PRS-220 for the treatment of IPF. selected to receive a Bavarian government grant of approximately $17 million to evaluate the program for post-COVID pulmonary fibrosis On 8/16/2021 Morgan Stanley reported 1,675,969 shares of PIRS for $6.42Mil, an increase of +104.6% for an ownership of 2.512% in the company On 4/26/2021 HC Wainwright brokerage Reiterated Rating to Buy and a price target of $9.00 On 6/30/2021 Jefferies Financial Group brokerage Boosted Price Target to Buy from $6.00 to $8.00 Usually i have price targets lower than most analysts, but on PIRS, my price target is 10usd. I`m looking forward to read your opinion about it.
NASDAQ:PIRSLong
by TopgOptions
4
OGI Organigram Holdings Great Earnings Call and Price Targets OGI is free of any significant debt after repaying our entire term loan balance of 58.5 million! The company currently has 220 million in cash and short-term investments! The Market Cap is only 880.85M! Q3 results: - Gross revenue grew 51% from Q2 2021 to 31% from the same period in fiscal 2020 to 29.1 million. - Net revenue grew 39% from Q2 and 13% from the same prior-year period, respectively, to 20.3 million. - Cost of sales decreased 47% to 23.4 million from Q3 of 2020 - IFRS gross margin increased to a positive 2.1 million from a negative 50 million in Q3 of 2020, largely due to lower cost of sales - net loss in Q3 of 2021 was reduced from Q3 2020 loss of 90 million to 4 million. Tobacco giant BIT British American Tobacco made an investment in Canadian pot grower OGI Organigram Holdings. BIT has a 19.9% stake in Organigram for an investment equivalent to about $175 million. The partnership also gives OrganiGram an opportunity to expand into the U.S. and new international markets. 1. My medium term price target is 4.5usd based on the resistance level 2. Fibonacci extension tool has a price target of 5.45usd 3. Stifel Nicolaus brokerage has a price target for OGI of $6.00 Did you know that you can buy it now similar to the price British American Tobacco paid for OGI Organigram Holdings?
NASDAQ:OGILong
by TopgOptions
3
EBON Ebang Int. buy it cheaper than BlackRock !!On 5/7/2021 BlackRock Inc. held 858,760 shares of EBON Ebang International for a market value of $6.83Mil. If we divide the value by the shares we will end up with an average price of 7.95usd per share. And i don`t think they are willing to sell at a loss. So if you buy EBON now, you will enter better than BlackRock Inc. Isn`t it fantastic? We see a strong support at 2.90usd and the last support at 2.40usd. The upside is the 8usd resistance. The price is now 3usd. So you risk 20% for a potential gain of 165%! I look forward to read your opinion on it!
NASDAQ:EBONLong
by TopgOptions
3
RSLS ReShape Lifesciences Global Weight-Loss Leader | $ TargetOn 6/17/2021 Alliance Global Partners brokerage Boosted the Price Target for RSLS ReShape Lifesciences stock from $12.00 to $18.50! ReShape Lifesciences is America's premier weight-loss solutions company. The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. Reshapecare™ virtual health coaching program is a virtual telehealth weight management program that supports lifestyle changes for all weight-loss patients, to help them keep the weight off over time. (accesswire.com) My price target is 12usd short term.
NASDAQ:RSLSLong
by TopgOptions
7